Physician profile
Mohiuddin Cheema
NPI 1174687248
$228,401.09
in general payments reported to CMS, 2019-2025
21 companies · $12K in 2025
The $12K reported for 2025 was more than what 92% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $49K · 2021: $48K · 2022: $42K · 2023: $28K · 2024: $29K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $30K · Consulting Fee: $26K · Food and Beverage: $9,284 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $30,127.21 |
| Consulting Fee | $25,950.00 |
| Food and Beverage | $9,284.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $198,154.91 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $13,349.55 | 2022-2025 | Endurant Iis, Valiant Captivia, Corevalve Evolut R |
| Inari Medical, INC. | $3,973.46 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $3,080.38 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Product In Development, Gore Tag Thoracic Endoprosthesis |
| Bolton Medical INC | $2,719.24 | 2019-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Angiodynamics, INC. | $2,237.31 | 2025 | Angiovac, Alphavac |
| Medtronic Vascular, INC. | $1,717.08 | 2019-2020 | |
| Penumbra, INC. | $1,538.01 | 2021-2023 | Indigo System |
| Artivion, INC. | $318.70 | 2019-2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Abbott Laboratories | $277.73 | 2019-2025 | Navitor, Thoratec Heartmate 3 Lvas Implant Kit |
| Shockwave Medical, INC | $176.83 | 2025 | |
| Lemaitre Vascular, INC. | $163.13 | 2024-2025 | Restoreflow, Tyke, Patch, Pledget and Intracardiac, Pruitt Irrigation Occlusion Catheter |
| Atricure, INC. | $147.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2019 | |
| Siemens Medical Solutions USA, INC. | $102.28 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $87.68 | 2022 | |
| Philips North America LLC | $85.95 | 2022 | |
| Abiomed | $58.08 | 2020 | |
| Endologix LLC | $47.64 | 2024 | Afx2 Bifurcated Endograft System |
| Boston Scientific Corporation | $24.37 | 2020 | |
| Kci USA, INC. | $15.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohiuddin Cheema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.